Pharmafile Logo
Pharmafocus logo
Advanced Search

Janssen

Showing 15 posts of 276 posts found.

Pfizer image

Pfizer/Janssen Alzheimer’s drug dropped after failure

August 7, 2012
Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen have decided to drop their investigational Alzheimer’s drug bapineuzumab after it failed a second late-stage study. The …

News
Care4today image

Janssen launches drug reminder service ‘Care4Today’

July 26, 2012
Medical Communications Care4Today, Janssen, digital

Janssen has launched a new digital service designed to help patients remember to take their medication. Care4Today Mobile Adherence is …

News
Velcade image

Speedy approval for Onyx’ multiple myeloma drug

July 24, 2012
Research and Development, Sales and Marketing FDA, Janssen, Kyprolis, Onyx, Takeda, Velcade

Onyx’ Kyprolis has gained an accelerated approval by the FDA to treat patients with late-stage multiple myeloma.  Kyprolis (carfilzomib), a …

News

Pfizer and Janssen’s Alzheimer’s drug fails

July 24, 2012
Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen’s investigational Alzheimer’s drug bapineuzumab is no better than placebo, according to a new study. The Phase III …

News
Janssen image

Janssen buys into regenerative diabetes portfolio

July 11, 2012
Research and Development, Sales and Marketing CureBeta, Evotec, Janssen, diabetes

Janssen has licensed a portfolio of drugs designed to regenerate insulin-producing beta cells. Janssen will receive exclusive access to a …

News
Xarelto image

Priority review for Xarelto’s new indications

July 10, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Boehringer, Eliquis, FDA, Janssen, Pradaxa, Xarelto

Xarelto is to be given a FDA fast-track review for a range of anti-blood clotting uses. Xarelto (rivaroxaban) gained its …

News
FDA image

Janssen submits tuberculosis pill to FDA

July 4, 2012
Research and Development, Sales and Marketing Bedaquiline, FDA, J&J, JJ, Janssen, tuberculosis

Janssen has submitted its investigational tuberculosis pill bedaquiline for review by the FDA. The firm is seeking a licence for …

News
Tarceva image

NICE final yes for Zytiga and Tarceva

June 27, 2012
Sales and Marketing Janssen, NHS, NICE, NSCLC, Roche, Tarceva, Zytiga

In final guidance published today, NICE is recommending two new drugs for patients with prostate and lung cancer. Janssen’s Zytiga …

News
Zytiga image

Janssen looks to broaden Zytiga licence

June 18, 2012
Sales and Marketing Cancer, Janssen, NICE, Provenge, Zytiga, prostate

Janssen is looking to broaden the licence for its prostate cancer pill Zytiga. Zytiga currently has a US and European …

News
Jane Griffiths

Working Life: Jane Griffiths

June 11, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Working Life, brett wells, jane griffiths

After completing her PhD in Biochemistry at the University of Aberystwyth in 1982, Jane worked her way up the Johnson …

Feature

UK Prix Galien shortlist announced

May 30, 2012
Business Services, Medical Communications, Research and Development, Sales and Marketing Bayer, Janssen, Xarelto, awards, prix galien

The UK award for the most innovative new drug has been moved a step closer with the release of a …

News
Richard Bergstrom

Public-private alliance to discover new antibiotics

May 25, 2012
AstraZeneca, EFPIA, GSK, Janssen, Sanofi, antibiotic, bacterial infection

 A Europe-wide public-private partnership is to put €224m (£180m) into finding new antibiotics for all manner of bacterial infections such …

News
Victrelis picture

Two new hep C pills recommended by NICE

April 25, 2012
Sales and Marketing Incivo, Janssen, MSD, NICE, Victrelis, hep C

NICE has given its final recommendation for two new hepatitis C pills in an expedited review.  Janssen’s Incivo (telaprevir) and …

News
Risperdal image

J&J fined after ‘lying to patients for profit’

April 16, 2012
Medical Communications, Sales and Marketing J&J, JJ, Janssen, Risperdal, US

A US judge has slapped a $1.19 billion fine on Johnson & Johnson after it was found to be downplaying …

News
Psoriasis Facebook image

Janssen to remove its Psoriasis 360 Facebook page

March 28, 2012
Medical Communications Facebook, Janssen, PM Soc, Psoriasis 360

Janssen has decided to take down its award-winning Psoriasis 360 page on Facebook, citing an increasing amount of troublesome comments. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025